Special article
Iodine supplementation during pregnancy and lactation. Position statement of the Working Group on Disorders Related to Iodine Deficiency and Thyroid Dysfunction of the Spanish Society of Endocrinology and NutritionSuplementación con yodo durante el embarazo y la lactancia. Toma de posición del Grupo de Trabajo de Trastornos relacionados con la Deficiencia de Yodo y Disfunción Tiroidea de la Sociedad Española de Endocrinología y Nutrición

https://doi.org/10.1016/j.endoen.2014.01.009Get rights and content

Abstract

Severe iodine deficiency and mild iodine deficiency during pregnancy and lactation affect thyroid function of the mother and neonate as well as the infant's neuropsychological development. Studies performed in Spain confirm that most women are iodine deficient during pregnancy and lactation. Pregnant and breast feeding women and women planning to become pregnant should take iodine supplements.

Resumen

La deficiencia de yodo grave y moderada durante el embarazo y la lactancia afecta a la función tiroidea de la madre y del neonato, así como al desarrollo neuropsicológico del niño. Estudios realizados en España confirman que la mayoría de las mujeres se encuentran en yododeficiencia durante la gestación y la lactancia. Las mujeres embarazadas, las que amamantan a sus hijos y las que planifican su gestación deberían recibir suplementos de yodo.

Introduction

On October 30, 2012, a workshop on “Iodine and folic acid supplementation during pregnancy and lactation” organized by the Directorate of Public Health of the Basque Government and the Directorate General of Research and Public Health of the Valencian Government was held in Bilbao, Spain. The final recommendations of this workshop (BW)1 included the following conclusion, based on the statement that iodine contents of iodinated salt (IS), milk, and dairy products are sufficient to cover iodine requirements in pregnancy and lactation provided the mother takes these products adequately: “Universal supplementation with (potassium iodide) tablets during pregnancy and breast-feeding is not currently justified in Spain”. Thus, according to the conclusions of the workshop, pharmacological iodine supplementation during pregnancy and lactation should be selective, and should only be prescribed to women at a high risk of inadequate iodine intake or the development of thyroid dysfunction at these stages.1

Less than three weeks before the BW, the journal Endocrinología y Nutrición had published an editorial signed by the Working Group on Disorders Related to Iodine Deficiency and Thyroid Dysfunction (IDD-TD) entitled “Eradication of iodine deficiency in Spain. Close but not there yet”.2 This article alerted its readers to the risk that the currently adequate iodine nutritional status in Spanish children and adults, mainly achieved through silent or uncontrolled iodine prophylaxis, could change and iodine deficiency (ID) could reappear, as has recently occurred in other European countries.3

Because of the almost simultaneous dissemination of two documents proposing conflicting strategies for ID correction, our Working Group on IDD-TD considered it indispensable to analyze the BW document, disseminated by electronic means, not published in any scientific journal, and which has not been explicitly endorsed either by the Working Group on IDD-TD as such, or by other scientific bodies (Spanish Society of Gynecology and Obstetrics, Spanish Society of Family and Community Medicine, Spanish Society of Rural and General Practitioners, Spanish Society of General Practitioners, Spanish Pediatrics Society) whose members are implicated in the management of iodine supplementation to pregnant or lactating women.

This article analyzes changes over time in the correction of gestational ID in Spain and reviews the evidence available on iodine supplementation in pregnant and lactating women, taking into account that iodine requirements in these two groups are almost double those of the remaining adult population.

Section snippets

Changes over time in iodine deficiency in Spain

After more than four decades of documented ID in Spain, in 2004 the World Health Organization (WHO) included Spain among the countries with optimum iodine nutrition.4 Several recent studies conducted in schoolchildren,5 adults,6 and pre-schoolchildren7 show median urinary iodine levels higher than 100 μg/L confirming iodine sufficiency in those groups of the Spanish population. However, as reported by some authors8 in similar circumstances to those found in Spain, pregnant women may still have

Limitations of standard iodine prophylaxis for the correction of iodine deficiency during pregnancy and lactation

Pregnant women experience a number of physiological changes in iodine metabolism, including increased urinary iodine excretion, iodine transfer from maternal circulation to the fetoplacental unit, and increased iodine requirements of the fetal thyroid gland from the second half of pregnancy.30 Daily iodine requirements also increase during lactation due to iodine concentration in breast milk.31

In the general population, the routine use of IS, either individually (if present in more than 90% of

Benefits and risks of pharmacological iodine supplementation

In pregnant women, a lack of iodine in their diet leads to an ID status that subsequently affects the fetus. Under these circumstances, maternal hypothyroxinemia, negatively affecting fetal brain development and aggravated by fetal hypothyroidism, occurs.39 Cretinism represents the most severe form of the broad spectrum of developmental changes of the central nervous system caused by maternal ID, with various grades of intellectual impairment depending on ID severity.40 Many epidemiological

Recommendations of professional bodies for the prevention and correction of iodine deficiency during pregnancy and lactation

Ideally, standard iodine prophylaxis measures such as routine IS consumption should ensure the adequate replenishment of thyroid iodine deposits before pregnancy. However, as previously discussed, the current situation in Spain and most other European countries is far from this ideal situation.26 During the past decades, there has been a gradual decrease in dietary iodine intake in most Western countries related, among other factors, to the decreased iodine contents of dairy products,

Conclusions

The correction of ID in Spain achieved in 2004, mainly through silent or uncontrolled iodine prophylaxis, has failed to decrease the risk of ID in pregnant and lactating women. A similar situation is found in virtually all Spanish regions. The proven lack of efficacy of iodine prophylaxis through iodine intake in the food chain to correct ID in the pregnant population, despite the fact that Spain was already among the countries with an optimum iodine nutrition, prompted the recommendation of

References (73)

  • M.B. Zimmermann

    Iodine deficiency and the effects of maternal iodine supplementation on the offspring: a review

    Am J Clin Nutr

    (2009)
  • R. Romano et al.

    The effects of iodoprophylaxis on thyroid size during pregnancy

    Am J Obstet Gynecol

    (1991)
  • S. Axford et al.

    Improved iodine status in breastfeeding women following mandatory fortification

    Aust N Z J Public Health

    (2011)
  • Suplementación con Yodo y Ácido Fólico durante el embarazo y la lactancia. Resumen y recomendaciones del taller llevado...
  • L. Vila et al.

    Nutrición de yodo de la población escolar de España (6–7 años): estudio Tirokid

    Endocrinol Nutr

    (2012)
  • J. Arena et al.

    Study of iodine intake in children from 6 months to three years-old in Guipúzcoa

    An Pediatr (Barc)

    (2012)
  • E.M. Wong et al.

    Comparison of median urinary iodine concentration as an indicator of iodine status among pregnant women, school-age children, and nonpregnant women

    Food Nutr Bull

    (2011)
  • T. Arrobas-Velilla et al.

    Nutrition iodine status in pregnant women in the sanitary district Sierra de Huelva-Andévalo, south of Spain

    Rev Invest Clin

    (2011)
  • S. Donnay

    Rational use of potassium iodide during pregnancy and lactation

    Endocrinol Nutr

    (2008)
  • Reaching optimal iodine nutrition in pregnant and lactating women and young children. Joint statement of the World Health Organization and the United Nations Children's Fund

    (2007)
  • P. Martull et al.

    Indicaciones del tratamiento con yodo a las embarazadas. Situación en Bizkaia

    Boletín S Vasco-Nav Pediatr

    (2007)
  • A. Maldonado et al.

    Yododeficiencia en mujeres gestantes del Área Sanitaria de Palencia (España)

    Endocrinol Nutr

    (2009)
  • M.C. González et al.

    Valoración del estado de nutrición yódica y niveles de tiroxinemia en mujeres embarazadas de diferentes áreas geográficas de Castilla y León

    Endocrinol Nutr

    (2011)
  • J.I. Jaen et al.

    Incidence of postpartum tiroiditis and study of posible associated factors

    Med Clin (Barc)

    (2009)
  • F. Almodóvar et al.

    Déficit de yodo en una población de mujeres embarazadas pertenecientes a un área con leve deficiencia de yodo

    Endocrinol Nutr

    (2006)
  • J. Sánchez-Vega et al.

    Inadequate iodine nutrition of pregnant women from Extremadura (Spain)

    Eur J Endocrinol

    (2008)
  • L. Vila et al.

    Iodine status and thyroid volume changes during pregnancy: results of a survey in Aran Valley (Catalan Pyrenees)

    J Endocrinol Invest

    (2008)
  • M. Rebagliato et al.

    Iodine intake and maternal thyroid function during pregnancy

    Epidemiology

    (2010)
  • M.P. Bonet et al.

    Concentraciones de yodo y su ingesta en una población de mujeres embarazadas sanas

    Enferm Clin

    (2007)
  • B. Peris et al.

    Embarazo y déficit de yodo. Situación actual

    Endocrinol Nutr

    (2009)
  • J. Soler Ramón et al.

    Manifiesto sobre la erradicación de la deficiencia de yodo en España. Málaga 2004

    Prog Diag Trat Prenat

    (2005)
  • M. Puig-Domingo et al.

    Iodine status, thyroid and pregnancy

    Hot Thyroidol ETA

    (2010)
  • M. Puig-Domingo et al.

    The implications of iodine and its supplementation during pregnancy in fetal brain development

    Curr Clin Pharmacol

    (2013)
  • F. Soriguer et al.

    Clinical dilemas arising from the increased intake oh iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women

    J Endocrinol Invest

    (2009)
  • D. Glinoer

    The importance of iodine nutrition during pregnancy

    Public Health Nutr

    (2007)
  • Cited by (0)

    Please cite this article as: Donnay S, Arena J, Lucas A, Velasco I, Ares S, en nombre del Grupo de Trabajo sobre Trastornos relacionados con la Deficiencia de Yodo y Disfunción Tiroidea de la Sociedad Española de Endocrinología y Nutrición. Suplementación con yodo durante el embarazo y la lactancia. Toma de posición del Grupo de Trabajo de Trastornos relacionados con la Deficiencia de Yodo y Disfunción Tiroidea de la Sociedad Española de Endocrinología y Nutrición. Endocrinol Nutr. 2014;61:27–34.

    The names of the members of the group Working Group related to Iodine Deficiency and Thyroid Dysfunction of the Spanish Society of Endocrinology and Nutrition are listed in Annex 1 to the end of Article Disorders.

    View full text